Related Experiment Video
Updated: Jun 21, 2026
A Screenable In Vivo Assay for Mitochondrial Modulators Using Transgenic Bioluminescent Caenorhabditis elegans
Published on: October 16, 2015
LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans
Shamol Saha1, Maria D Guillily, Andrew Ferree
1Department of Pharmacology, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Abstract:
Mutations in leucine-rich repeat kinase 2 (LRRK2) cause autosomal-dominant familial Parkinson's disease. We generated lines of Caenorhabditis elegans expressing neuronally directed human LRRK2. Expressing human LRRK2 increased nematode survival in response to rotenone or paraquat, which are agents that cause mitochondrial dysfunction. Protection by G2019S, R1441C, or kinase-dead LRRK2 was less than protection by wild-type LRRK2. Knockdown of lrk-1, the endogenous ortholog of LRRK2 in C. elegans, reduced survival associated with mitochondrial dysfunction. C. elegans expressing LRRK2 showed rapid loss of dopaminergic markers (DAT::GFP fluorescence and dopamine levels) beginning in early adulthood. Loss of dopaminergic markers was greater for the G2019S LRRK2 line than for the wild-type line. Rotenone treatment induced a larger loss of dopamine markers in C. elegans expressing G2019S LRRK2 than in C. elegans expressing wild-type LRRK2; however, loss of dopaminergic markers in the G2019S LRRK2 nematode lines was not statistically different from that in the control line. These data suggest that LRRK2 plays an important role in modulating the response to mitochondrial inhibition and raises the possibility that mutations in LRRK2 selectively enhance the vulnerability of dopaminergic neurons to a stressor associated with Parkinson's disease.
Insights
Leucine-rich repeat kinase 2 (LRRK2) protects against mitochondrial toxins in C. elegans. Mutations linked to Parkinson's disease may increase dopaminergic neuron vulnerability to such stressors.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Mutations in leucine-rich repeat kinase 2 (LRRK2) are a primary cause of autosomal-dominant familial Parkinson's disease.
- LRRK2's precise role in neuronal function and disease pathogenesis remains under investigation.
Purpose of the Study:
- To investigate the function of human LRRK2 in a Caenorhabditis elegans model.
- To determine the impact of LRRK2 and its Parkinson's-associated mutations on neuronal survival and dopaminergic neuron integrity under stress.
Main Methods:
- Generated C. elegans lines expressing neuronally directed human LRRK2 (wild-type and mutant forms).
- Assessed nematode survival following exposure to rotenone and paraquat (mitochondrial toxins).
- Quantified dopaminergic markers (DAT::GFP fluorescence, dopamine levels) in aging worms.
Main Results:
- Human LRRK2 expression enhanced nematode survival against rotenone and paraquat.
- Parkinson's-associated LRRK2 mutations (G2019S, R1441C) conferred less protection than wild-type LRRK2.
- LRRK2 expression led to a loss of dopaminergic markers, with greater loss observed in the G2019S mutant line.
Conclusions:
- LRRK2 plays a significant role in modulating cellular responses to mitochondrial stress.
- LRRK2 mutations may selectively increase the susceptibility of dopaminergic neurons to Parkinson's-associated stressors.
